IKCS Europe 2022 

DNA Assay May Distinguish Responses to mRCC Immunotherapy

The TARDIS assay could be used to identify appropriate candidates for discontinuation of immune checkpoint inhibitors.

Efficacy, Safety of Triple Combo for Advanced Kidney Cancer Probed

Study provides preliminary data on triple therapy for advanced RCC while clinicians await definitive answers from the ongoing phase 3 COSMIC-313 trial.

Treatment Advances Have Upped Survival in Metastatic Kidney Cancer

Investigators in Austria studied overall survival in 914 patients diagnosed with mRCC from July 1985 to September 2020.

COVID-19 mRNA Vaccine Efficacy Wanes Over Time in RCC Cases

Strategies such as booster doses appear warranted in this population.

Kidney Cancer Metastases Effectively Treated With Robotic Radiosurgery

Investigators examined outcomes of robotic radiosurgery in patients with lung, visceral, and lymph node metastases from renal cell carcinoma.

Lenvatinib+Pembrolizumab Adverse Reactions in Advanced RCC Characterized

Investigators describe the type and frequency of adverse reactions and how clinicians managed them.

Frontline Immunotherapy Appears Effective in mRCC With Poor Performance Status

Patients with poor performance status have been excluded from pivotal trials on metastatic renal cell carcinoma.